Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
SPECIAL PRECAUTIONS FOR STORAGE
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 10506) by Elizabeth McDonald, MD, PhD, a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing breast radiologist at Penns Abramson Cancer Center
THE FELLA 6-MONTH MONEY-BACK GUARANTEE All Fella plans come with a full six-month money-back guarantee
Stability Information Freeze for storageRefrigerate after reconstitutionProtect from light Lyophilized (powder) -20C 24+ months Reconstituted 2-8C ~30 days Sources & References Peer-reviewed research NEW ENGLAND JOURNAL OF MEDICINE TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial 2023DOI: 10.1056/NEJMoa2301972 Jastrehoff AM, et al
US$ 22.36
US$ 23.97
US$ 27.64
US$ 25.45
US$ 21.32
US$ 22.36
US$ 21.83
US$ 29.43
US$ 29.37
US$ 23.91
US$ 27.00
US$ 27.90
US$ 26.40
